NEWS - Apr 28, 2020 Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs Read more
NEWS - Mar 31, 2020 Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety Read more
NEWS - Mar 24, 2020 Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development Read more
NEWS - Mar 9, 2020 Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development Read more
NEWS - Feb 25, 2020 Relmada Therapeutics to Present at 9th Annual SVB Leerink Global Healthcare Conference Read more
NEWS - Jan 10, 2020 Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer Read more
NEWS - Dec 20, 2019 Relmada Therapeutics Strengthens Board of Directors with Appointments of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool Read more
NEWS - Dec 9, 2019 Relmada Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Read more
NEWS - Dec 3, 2019 Relmada Therapeutics Announces Pricing of Public Offering of Common Stock Read more